Balentine LLC Teva Pharmaceutical Industries LTD Transaction History

Balentine LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Oct 26, 2022	BUY	$7.9 - $10.19 $87,271 - $112,568	11,047 New	11,047 $88,000
Q3 2020 Nov 02, 2020	SELL	$8.57 - $12.69 $3,308 - $4,898	-386 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $3,134 - $5,064	386 New	386 $5,000
Q4 2019 Sep 02, 2020	SELL	$6.53 - $10.72 $1,710 - $2,808	-262 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$6.16 - $9.6 $227 - $355	37 Added 16.44%	262 $2,000
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $3,897 - $7,545	-480 Reduced 68.09%	225 $2,000
Q1 2019 May 16, 2019	BUY	$15.58 - $20.01 $10,983 - $14,107	705 New	705 $11,000
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $25,692 - $41,982	-1,761 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $37,086 - $45,169	1,761 New	1,761 $38,000
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $3,009 - $5,118	-268 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$15.41 - $32.17 $4,129 - $8,621	268	268 $5,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.